Home›Companies›Healthcare›GelSana

GelSana Therapeutics, Inc.

Makes wound dressings for patients under the care of healthcare professionals.

Updated Nov 9, 2026·Latest SEC filing Oct 8, 2026·Suggest an edit

About GelSana

GelSana is a private company based in Aurora, Colorado. It has reported $4,352,701 raised in one offering on Form D since December 2023. Its chief executive is Melissa Krebs.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 20, 2023Dec 4, 2023amended Oct 8, 2026$4,352,701of $4.9M target33$131KEquityRule 506(b)Form D/A ↗3 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on GelSana's Form D filed Oct 8, 2026.

Melissa Krebs
Melissa Krebs
Founder and CEO, director
Mike Freeman
Mike Freeman
Board Member
Also a director at Origin Endoscopy.
Diana Verrilli
Diana Verrilli
Board Member

Sources

  1. SECGelSana Therapeutics, Inc. Form D/A, filed Mar 6, 2026
  2. SECGelSana Therapeutics, Inc. Form D/A, filed Aug 14, 2024
  3. SECGelSana Therapeutics, Inc. Form D, filed Dec 4, 2023
  4. SECGelSana Therapeutics, Inc. filing history
  5. CompanyAbout GelSana
  6. ResearchColorado School of Mines on CleraFlex